Cyfuse Biomedical K.K. Logo

Cyfuse Biomedical K.K.

4892 | T

Overview

Corporate Details

ISIN(s):
JP3311800001
LEI:
Country:
Japan
Address:
港区三田3−5−27 住友不動産三田ツインビル西館
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cyfuse Biomedical K.K. is a pioneering Japanese company specializing in innovative bioprinting technologies. Based in Tokyo with an additional office in Fukuoka, Cyfuse focuses on the development of advanced tissue engineering solutions, utilizing its proprietary 3D bioprinting platform. The company aims to revolutionize regenerative medicine by creating functional, living tissues for therapeutic applications, including drug testing and personalized medicine. With a commitment to research and development, Cyfuse Biomedical is at the forefront of transforming healthcare solutions and addressing critical challenges in tissue regeneration. Through its cutting-edge technology, Cyfuse is poised to make a significant impact on the future of medical treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:31
Regulatory News Service
確認書
Japanese 9.0 KB
2025-08-14 08:30
Interim Report
半期報告書-第16期(2025/01/01-2025/12/31)
Japanese 359.3 KB
2025-05-30 08:30
Registration Form
有価証券届出書(組込方式)
Japanese 924.1 KB
2025-03-26 03:03
Post-Annual General Meeting Information
臨時報告書
Japanese 21.4 KB
2025-03-26 03:02
Governance Information
内部統制報告書-第15期(2024/01/01-2024/12/31)
Japanese 22.7 KB
2025-03-26 03:01
Registration Form
有価証券報告書-第15期(2024/01/01-2024/12/31)
Japanese 2.2 MB
2025-03-26 03:01
Registration Form
確認書
Japanese 9.0 KB
2025-02-25 08:30
Audit Report / Information
臨時報告書
Japanese 20.6 KB
2024-08-14 08:33
Interim Report
確認書
Japanese 9.0 KB
2024-08-14 08:32
Interim Report
半期報告書-第15期(2024/01/01-2024/12/31)
Japanese 234.3 KB
2024-05-15 09:16
Report Publication Announcement
確認書
Japanese 9.0 KB
2024-05-15 09:15
Quarterly Report
四半期報告書-第15期第1四半期(2024/01/01-2024/03/31)
Japanese 196.4 KB
2024-04-17 10:10
Remuneration Information
臨時報告書
Japanese 43.2 KB
2024-03-27 08:18
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2024-03-27 08:17
Governance Information
内部統制報告書-第14期(2023/01/01-2023/12/31)
Japanese 22.8 KB

Automate Your Workflow. Get a real-time feed of all Cyfuse Biomedical K.K. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cyfuse Biomedical K.K.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cyfuse Biomedical K.K. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Dottikon ES Holding AG Logo
Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.
Switzerland
DESN
Double Bond Pharmaceutical International AB Logo
Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.
Sweden
DBP B
DR REDDYS LABORATORIES LTD Logo
Global pharma firm providing affordable generics, APIs, and medicines to patients worldwide.
United States of America
RDY
Develops & commercializes PET/CT tracers for diagnosing cancer & neurological disorders.
South Korea
176750
Dx & Vx Co., Ltd. Logo
Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.
South Korea
180400
DYNAVAX TECHNOLOGIES CORP Logo
Biopharma firm developing novel vaccines, like its adult hepatitis B vaccine, with adjuvant tech.
United States of America
DVAX
Dyne Therapeutics, Inc. Logo
Developing targeted therapies for genetic neuromuscular diseases via its FORCE™ platform.
United States of America
DYN
Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.
South Korea
044960
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom
EAH
Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden
ECTIN B

Talk to a Data Expert

Have a question? We'll get back to you promptly.